(1) Andersen DC and Krummen L. Recombinant protein
expression for therapeutic applications. Curr. Opin.
Biotechnol. (2002) 13: 117-23.
(2) Khan KH. Gene expression in mammalian cells and
its applications. Adv. Pharm. Bull. (2013) 3: 257-63.
(3) Babaeipour V, Vahidi H, Alikhani S, Ranjbari
J, Alibakhshi A and Tabarzad M. Effect of acyl
homoserine lactone on recombinant production of
human insulin-like growth factor-1 in batch culture
of Escherichia coli. Protein Pept. Lett. (2018) 25:
980-5.
(4) Baik JY, Dahodwala H, Oduah E, Talman L, Gemmill
TR and Gasimli L. Optimization of bioprocess
conditions improves production of a CHO cell‐
derived, bioengineered heparin. Biotechnol. J.
(2015) 10: 1067-81.
(5) Ranjbari J, Babaeipour V, Vahidi H, Moghimi
H, Mofid MR and Namvaran MM. Enhanced
production of insulin-like growth factor I protein in
Escherichia coli by optimization of five key factors.
Iran. J. Pharm. Res. (2015) 14: 907-17.
(6) Xing Z, Kenty B, Koyrakh I, Borys M, Pan SH and
Li ZJ. Optimizing amino acid composition of CHO
cell culture media for a fusion protein production.
Process Biochem. (2011) 46: 1423-9.
(7) Altamirano C, Paredes C, Cairo J and Godia
F. Improvement of CHO cell culture medium
formulation: simultaneous substitution of glucose
and glutamine. Biotechnol. Prog. (2000) 16: 69-75.
(8) Garcia-Kirchner O, Segura-Granados M and
Rodriguez-Pascual P. Effect of media composition
and growth conditions on production of β-glucosidase
by Aspergillus niger C-6. Twenty-Sixth Symposium
on Biotechnology for Fuels and Chemicals. Springer
(2005).
(9) Even MS, Sandusky CB and Barnard ND. Serumfree hybridoma culture: ethical, scientific and safety
considerations. Trends Biotechnol. (2006) 24: 105-8.
(10) Shah G. Why do we still use serum in the production
of biopharmaceuticals? Dev. Biol. Stand. (1999)
99: 17-22.
(11) Ritacco FV, Wu Y and Khetan A. Cell culture
media for recombinant protein expression in
Chinese hamster ovary (CHO) cells: History,
key components, and optimization strategies.
Biotechnol. Prog. (2018) 34: 1407-26.
(12) Gstraunthaler G. Alternatives to the use of fetal
bovine serum: serum-free cell culture. ALTEX
(2003) 20: 275-81.
(13) Gu C, Li P, Liu W, Zhou Y and Tan WS. The
role of insulin in transdifferentiated hepatocyte
proliferation and function in serum‐free medium.
J. Cell. Mol. Med. (2019) 23: 4165-78.
(14) Bayat H, Hossienzadeh S, Pourmaleki E, Ahani R
and Rahimpour A. Evaluation of different vector
design strategies for the expression of recombinant
monoclonal antibody in CHO cells. Prep. Biochem.
Biotechnol. (2018) 48: 160-4.
(15) Saia-Cereda VM, Aquino A, Guest PC and Martinsde-Souza D. Two-dimensional gel electrophoresis:
A reference protocol. Adv. Exp. Med. Biol. (2017)
974: 175-82.
(16) Solanki AB, Parikh JR and Parikh RH. Formulation
and optimization of piroxicam proniosomes by
3-factor, 3-level Box-Behnken design. AAPS
PharmSciTech. (2007) 8: 43.
(17) Miki H and Takagi M. Design of serum-free
medium for suspension culture of CHO cells on the
basis of general commercial media. Cytotechnology
(2015) 67: 689-97.
(18) Xu J, Yan FR, Li ZH, Wang D, Sheng HL and Liu
Y. Serum-free medium optimization based on trial
design and support vector regression. Biomed. Res.
Int. (2014) 2014: 269305.
(19) Kim DY, Lee JC, Chang HN and Oh DJ. Development of serum-free media for a recombinant CHO
cell line producing recombinant antibody. Enzyme
Microb. Technol. (2006) 39: 426-33.